BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di J, Xie F, Xu Y. When liposomes met antibodies: Drug delivery and beyond. Adv Drug Deliv Rev 2020;154-155:151-62. [PMID: 32926944 DOI: 10.1016/j.addr.2020.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Lou J, Qualls ML, Best MD. Sticking the Landing: Enhancing Liposomal Cell Delivery using Reversible Covalent Chemistry and Caged Targeting Groups. Chembiochem 2023;24:e202200436. [PMID: 36164720 DOI: 10.1002/cbic.202200436] [Reference Citation Analysis]
2 Zuraw BL, Maurer M, Sexton DJ, Cicardi M. Therapeutic monoclonal antibodies with a focus on hereditary angioedema. Allergol Int 2023;72:54-62. [PMID: 35787344 DOI: 10.1016/j.alit.2022.06.001] [Reference Citation Analysis]
3 Song C, Xu J, Gao C, Zhang W, Fang X, Shang Y. Nanomaterials targeting macrophages in sepsis: A promising approach for sepsis management. Front Immunol 2022;13:1026173. [PMID: 36569932 DOI: 10.3389/fimmu.2022.1026173] [Reference Citation Analysis]
4 Reschke M, Piotrowski-Daspit AS, Pober JS, Saltzman WM. Nucleic Acid Delivery to the Vascular Endothelium. Mol Pharm 2022;19:4466-86. [PMID: 36251765 DOI: 10.1021/acs.molpharmaceut.2c00653] [Reference Citation Analysis]
5 Shan H, Sun X, Liu X, Sun Q, He Y, Chen Z, Lin Q, Jiang Z, Chen X, Chen Z, Zhao S. One‐Step Formation of Targeted Liposomes in a Versatile Microfluidic Mixing Device. Small 2022. [DOI: 10.1002/smll.202205498] [Reference Citation Analysis]
6 Zhang X, Bu X, Jia W, Ying Y, Lv S, Jiang G. Near-Infrared Light-Activated Oxygen Generator a Multidynamic Photo-Nanoplatform for Effective Anti-Cutaneous Squamous Cell Carcinoma Treatment. IJN 2022;Volume 17:5761-5777. [DOI: 10.2147/ijn.s378321] [Reference Citation Analysis]
7 Zhang Y, Fu H, Chen J, Xu L, An Y, Ma R, Zhu C, Liu Y, Ma F, Shi L. Holdase/Foldase Mimetic Nanochaperone Improves Antibody-Based Cancer Immunotherapy. Small Methods 2022;:e2201051. [PMID: 36228110 DOI: 10.1002/smtd.202201051] [Reference Citation Analysis]
8 Yuan D, Zhang Y, Lim KH, Leung SKP, Yang X, Liang Y, Lau WCY, Chow KT, Xia J. Site-Selective Lysine Acetylation of Human Immunoglobulin G for Immunoliposomes and Bispecific Antibody Complexes. J Am Chem Soc 2022. [PMID: 36167521 DOI: 10.1021/jacs.2c07594] [Reference Citation Analysis]
9 Javan Nikkhah S, Vandichel M. Modeling Polyzwitterion-Based Drug Delivery Platforms: A Perspective of the Current State-of-the-Art and Beyond. ACS Eng Au 2022;2:274-294. [DOI: 10.1021/acsengineeringau.2c00008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Xiao Q, Zoulikha M, Qiu M, Teng C, Lin C, Li X, Sallam MA, Xu Q, He W. The effects of protein corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev 2022;186:114356. [PMID: 35595022 DOI: 10.1016/j.addr.2022.114356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Wang X, Zhao W, Fan J, Jia L, Lu Y, Zeng L, Lv Y, Sun X. Tumor Tropic Delivery of Hyaluronic Acid-Poly (D,L-lactide-co-glycolide) Polymeric Micelles Using Mesenchymal Stem Cells for Glioma Therapy. Molecules 2022;27:2419. [DOI: 10.3390/molecules27082419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chen C, Zhou Y, Chen C, Zhu S, Yan X. Quantification of Available Ligand Density on the Surface of Targeted Liposomal Nanomedicines at the Single-Particle Level. ACS Nano 2022. [PMID: 35394292 DOI: 10.1021/acsnano.2c02084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Xiao Q, Li X, Liu C, Yang Y, Hou Y, Wang Y, Su M, He W. Liposome-based anchoring and core-encapsulation for combinatorial cancer therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lin X, Wu J, Liu Y, Lin N, Hu J, Zhang B. Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer. Molecules 2022;27:948. [DOI: 10.3390/molecules27030948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fobian SF, Cheng Z, Ten Hagen TLM. Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks. Pharmaceutics 2021;14:26. [PMID: 35056922 DOI: 10.3390/pharmaceutics14010026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zhang Y, Yue S, Haag R, Sun H, Zhong Z. An intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer. J Control Release 2021;340:331-41. [PMID: 34774889 DOI: 10.1016/j.jconrel.2021.11.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Xing L, Liu XY, Zhou TJ, Wan X, Wang Y, Jiang HL. Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy. J Control Release 2021;339:14-26. [PMID: 34547257 DOI: 10.1016/j.jconrel.2021.09.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
18 Yu N, Zhang Y, Li J, Gu W, Yue S, Li B, Meng F, Sun H, Haag R, Yuan J, Zhong Z. Daratumumab Immunopolymersome-Enabled Safe and CD38-Targeted Chemotherapy and Depletion of Multiple Myeloma. Adv Mater 2021;33:e2007787. [PMID: 34369013 DOI: 10.1002/adma.202007787] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
19 Gew LT, Misran M. PEGylated DPPC/Anti-SNAP25 Antibody Targeted Liposomes from Langmuir Monolayer Study to Formulations. CCB 2021;15:249-261. [DOI: 10.2174/2212796815666210804111958] [Reference Citation Analysis]
20 van Alem CMA, Metselaar JM, van Kooten C, Rotmans JI. Recent Advances in Liposomal-Based Anti-Inflammatory Therapy. Pharmaceutics 2021;13:1004. [PMID: 34371695 DOI: 10.3390/pharmaceutics13071004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kouhpayeh S, Shariati L, Boshtam M, Rahimmanesh I, Mirian M, Esmaeili Y, Najaflu M, Khanahmad N, Zeinalian M, Trovato M, Tay FR, Khanahmad H, Makvandi P. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. Int J Mol Sci 2021;22:5438. [PMID: 34064039 DOI: 10.3390/ijms22115438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
22 Castellino S, Lareau NM, Groseclose MR. The emergence of imaging mass spectrometry in drug discovery and development: Making a difference by driving decision making. J Mass Spectrom 2021;56:e4717. [PMID: 33724654 DOI: 10.1002/jms.4717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Luo G, Zhang J, Sun Y, Wang Y, Wang H, Cheng B, Shu Q, Fang X. Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis. Nanomicro Lett 2021;13:88. [PMID: 34138348 DOI: 10.1007/s40820-021-00598-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Narayanaswamy R, Torchilin VP. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy. Pharm Res 2021;38:429-50. [PMID: 33655395 DOI: 10.1007/s11095-021-02986-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
25 Wei C, Wang P, Huang Z, He D, Zhu W, Liu H, Chen Z, Wang W, Li Y, Shen J, Qin L. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy. Mol Pharm 2021;18:1327-43. [PMID: 33530691 DOI: 10.1021/acs.molpharmaceut.0c01164] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
26 Fitzgerald AA, Li E, Weiner LM. 3D Culture Systems for Exploring Cancer Immunology. Cancers (Basel) 2020;13:E56. [PMID: 33379189 DOI: 10.3390/cancers13010056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]